Literature DB >> 28031336

Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity.

Chi G Weindel1, Lauren J Richey2, Abhiruchi J Mehta3, Mansi Shah3, Brigitte T Huber4,3.   

Abstract

Individuals suffering from autoimmune disorders possess a hyperactive cellular phenotype where tolerance to self-antigens is lost. Autophagy has been implicated in both the induction and prevention of autoimmunity, and modulators of this cellular recycling process hold high potential for the treatment of autoimmune diseases. In this study, we determine the effects of a loss of autophagy in dendritic cells (DCs), as well as both B cells and DCs, in a TLR7-mediated model of autoimmunity, similar to systemic lupus erythematosus, where both cell types are critical for disease. Although a loss of DC autophagy slowed disease, the combined loss of autophagy in both cell types resulted in a lethal sepsis-like environment, which included tissue inflammation and hyperproduction of inflammasome-associated cytokines. Ablation of B cell signaling reversed this phenotype, indicating that activation of these cells is an essential step in disease induction. Thus, autophagy plays a dichotomous role in this model of disease.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28031336      PMCID: PMC5263064          DOI: 10.4049/jimmunol.1601307

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Rs548234 polymorphism at PRDM1-ATG5 region susceptible to rheumatoid arthritis in Caucasians is not associated with rheumatoid arthritis in Chinese Han population.

Authors:  Xiao-Lan Lu; Xu-Jie Zhou; Jian-Ping Guo; Ru-Lin Jia; Yi Zhao; Quan Jiang; Xiang-Yuan Liu; Yi Liu; Ling-Yun Sun; Hong Zhang; Zhan-Guo Li
Journal:  Chin Med J (Engl)       Date:  2011-09       Impact factor: 2.628

2.  In vivo requirement for Atg5 in antigen presentation by dendritic cells.

Authors:  Heung Kyu Lee; Lisa M Mattei; Benjamin E Steinberg; Philipp Alberts; Yun Hee Lee; Alexander Chervonsky; Noboru Mizushima; Sergio Grinstein; Akiko Iwasaki
Journal:  Immunity       Date:  2010-02-18       Impact factor: 31.745

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

Review 4.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?

Authors:  Karen H Costenbader; Steffen Gay; Marta E Alarcón-Riquelme; Luca Iaccarino; Andrea Doria
Journal:  Autoimmun Rev       Date:  2011-10-25       Impact factor: 9.754

5.  Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways.

Authors:  Yuko Hirota; Shun-ichi Yamashita; Yusuke Kurihara; Xiulian Jin; Masamune Aihara; Tetsu Saigusa; Dongchon Kang; Tomotake Kanki
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  A vesicular transport pathway shuttles cargo from mitochondria to lysosomes.

Authors:  Vincent Soubannier; Gian-Luca McLelland; Rodolfo Zunino; Emelie Braschi; Peter Rippstein; Edward A Fon; Heidi M McBride
Journal:  Curr Biol       Date:  2012-01-05       Impact factor: 10.834

7.  Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus.

Authors:  A Tincani; P L Meroni; A Brucato; C Zanussi; F Allegri; P Mantelli; R Cattaneo; G Balestrieri
Journal:  Clin Exp Rheumatol       Date:  1985 Oct-Dec       Impact factor: 4.473

8.  Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses.

Authors:  J Arnold; D Murera; F Arbogast; J-D Fauny; S Muller; F Gros
Journal:  Cell Death Differ       Date:  2015-11-20       Impact factor: 15.828

9.  Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room.

Authors:  Chia-Te Kung; Sheng-Yuan Hsiao; Tsung-Cheng Tsai; Chih-Min Su; Wen-Neng Chang; Chi-Ren Huang; Hung-Chen Wang; Wei-Che Lin; Hsueh-Wen Chang; Yu-Jun Lin; Ben-Chung Cheng; Ben Yu-Jih Su; Nai-Wen Tsai; Cheng-Hsien Lu
Journal:  J Transl Med       Date:  2012-06-21       Impact factor: 5.531

10.  High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry.

Authors:  Celi Sun; Julio E Molineros; Loren L Looger; Xu-Jie Zhou; Kwangwoo Kim; Yukinori Okada; Jianyang Ma; Yuan-Yuan Qi; Xana Kim-Howard; Prasenjeet Motghare; Krishna Bhattarai; Adam Adler; So-Young Bang; Hye-Soon Lee; Tae-Hwan Kim; Young Mo Kang; Chang-Hee Suh; Won Tae Chung; Yong-Beom Park; Jung-Yoon Choe; Seung Cheol Shim; Yuta Kochi; Akari Suzuki; Michiaki Kubo; Takayuki Sumida; Kazuhiko Yamamoto; Shin-Seok Lee; Young Jin Kim; Bok-Ghee Han; Mikhail Dozmorov; Kenneth M Kaufman; Jonathan D Wren; John B Harley; Nan Shen; Kek Heng Chua; Hong Zhang; Sang-Cheol Bae; Swapan K Nath
Journal:  Nat Genet       Date:  2016-01-25       Impact factor: 38.330

View more
  10 in total

1.  Podocytes and autophagy: a potential therapeutic target in lupus nephritis.

Authors:  Xu-Jie Zhou; Daniel J Klionsky; Hong Zhang
Journal:  Autophagy       Date:  2019-02-17       Impact factor: 16.016

Review 2.  Autophagy in major human diseases.

Authors:  Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 3.  Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.

Authors:  Tiffany Caza; Chathura Wijewardena; Laith Al-Rabadi; Andras Perl
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

Review 4.  The "Self-Sacrifice" of ImmuneCells in Sepsis.

Authors:  Xiaoyue Wen; Bing Xie; Shiying Yuan; Jiancheng Zhang
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

5.  Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.

Authors:  Yuan-Yuan Qi; Xu-Jie Zhou; Fa-Juan Cheng; Ping Hou; Ya-Li Ren; Su-Xia Wang; Ming-Hui Zhao; Li Yang; Jennifer Martinez; Hong Zhang
Journal:  Ann Rheum Dis       Date:  2018-09-12       Impact factor: 19.103

Review 6.  The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome.

Authors:  Carlene Petes; Natalya Odoardi; Katrina Gee
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

Review 7.  Autophagy in dendritic cells.

Authors:  Ghita Ghislat; Toby Lawrence
Journal:  Cell Mol Immunol       Date:  2018-03-26       Impact factor: 11.530

Review 8.  RNA Modifications Modulate Activation of Innate Toll-Like Receptors.

Authors:  Isabel Freund; Tatjana Eigenbrod; Mark Helm; Alexander H Dalpke
Journal:  Genes (Basel)       Date:  2019-01-29       Impact factor: 4.096

Review 9.  Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Fangyuan Yang; Yi He; Zeqing Zhai; Erwei Sun
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

Review 10.  Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer.

Authors:  Ali Zahedi-Amiri; Kyle Malone; Shawn T Beug; Tommy Alain; Behzad Yeganeh
Journal:  Cells       Date:  2021-10-06       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.